1.Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016.
Mei Wen YUAN ; Hong Hao WANG ; Ru Fei DUAN ; Kun Peng XU ; Shang Ying HU ; You Lin QIAO ; Yong ZHANG ; Fang Hui ZHAO
Chinese Journal of Epidemiology 2022;43(5):702-708
Objective: We aim to evaluate the morbidity and mortality of cancer attributable to human papillomavirus (HPV) infection in China in 2016. Methods: Based on the cancer incidence and mortality rates, national population data, and population attributable fraction (PAF) in China, we calculated the number of incidence and death cases attributed to HPV infection in different areas, age groups, and gender in China in 2016. The standardized incidence and mortality rates for cancer attributed to HPV infection were calculated by using Segi's population. Results: In 2016, a total of 124 772 new cancer cases (6.32 per 100 000) were attributed to HPV infection in China, including 117 118 cases in women and 7 654 cases in men. Of these cancers, cervical cancer was the most common one, followed by anal cancer, oropharyngeal cancer, penile cancer, vaginal cancer, laryngeal cancer, oral cancer, and vulvar cancer. A total of 41 282 (2.03 per 100 000) deaths were attributed to HPV infection, of which 37 417 occurred in women and 3 865 in men. Most deaths were caused by cervical cancer, followed by anal cancer, oropharyngeal cancer, penile cancer, laryngeal cancer, vaginal cancer, oral cancer, and vulvar cancer. The incidence and mortality rates of cervical cancer increased rapidly with age, peaked in age group 50-54 years, then decreased obviously. The morbidity and mortality rates of non-cervical cancer increased with age. The cancer case and death numbers in rural areas (57 089 cases and 19 485 deaths) were lower than those in urban areas (67 683 cases and 21 797 deaths). However, the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of cervical cancer were higher in rural areas than in urban areas. There were no significant differences in ASIR and ASMR of non-cervical cancers between urban areas and rural areas. Conclusions: The incidence of cancers attributed to HPV infection in China was lower than the global average, but the number of incidences accounted largely, furthermore there is an increasing trend of morbidity and mortality. The preventions and controls of cervical cancer and male anal cancer are essential to contain the increases in cancer cases and deaths attributed to HPV infection.
China/epidemiology*
;
Female
;
Humans
;
Incidence
;
Laryngeal Neoplasms
;
Male
;
Middle Aged
;
Mouth Neoplasms
;
Oropharyngeal Neoplasms/epidemiology*
;
Papillomavirus Infections/epidemiology*
;
Penile Neoplasms/epidemiology*
;
Registries
;
Uterine Cervical Neoplasms/epidemiology*
;
Vaginal Neoplasms
;
Vulvar Neoplasms
2.Epidemiology regarding penile prosthetic surgery.
Jose A SAAVEDRA-BELAUNDE ; Jonathan CLAVELL-HERNANDEZ ; Run WANG
Asian Journal of Andrology 2020;22(1):2-7
With the onset of a metabolic syndrome epidemic and the increasing life expectancy, erectile dysfunction (ED) has become a more common condition. As incidence and prevalence increase, the medical field is focused on providing more appropriate therapies. It is common knowledge that ED is a chronic condition that is also associated with a myriad of other disorders. Conditions such as aging, diabetes mellitus, hypertension, obesity, prostatic hypertrophy, and prostate cancer, among others, have a direct implication on the onset and progression of ED. Characterization and recognition of risk factors may help clinicians recognize and properly treat patients suffering from ED. One of the most reliable treatments for ED is penile prosthetic surgery. Since the introduction of the penile prosthesis (PP) in the early seventies, this surgical procedure has improved the lives of thousands of men, with reliable and satisfactory results. The aim of this review article is to characterize the epidemiology of men undergoing penile prosthetic surgery, with a discussion about the most common conditions involved in the development of ED, and that ultimately drive patients into electing to undergo PP placement.
Diabetes Complications/surgery*
;
Diabetes Mellitus/epidemiology*
;
Erectile Dysfunction/surgery*
;
Humans
;
Hypertension
;
Impotence, Vasculogenic/surgery*
;
Male
;
Pelvic Bones/injuries*
;
Penile Implantation/statistics & numerical data*
;
Penile Induration/surgery*
;
Penile Prosthesis
;
Penis/injuries*
;
Prostatectomy/adverse effects*
;
Prostatic Neoplasms/surgery*
;
Radiation Injuries/surgery*
;
Radiotherapy/adverse effects*
;
Reoperation
;
Spinal Cord Injuries/epidemiology*
;
Vascular Diseases/epidemiology*
;
Wounds and Injuries/epidemiology*